Driving Safety In Healthy Volunteers
SPTXSeaport TherapeuticsCatalyst overview
Research summary
This catalyst tracks a Phase 1 data readout for GlyphAllo/Glyph Allopregnanolone (SPT-300) (Neuroactive Steroid) in Driving Safety In Healthy Volunteers. The expected timing is based on the latest available company guidance and may change.
06/08/26:- First participant dosed in driving simulation trial; Ph1 data expected H2 2026. 08/03/26:- Driving simulation trial remains on track. Topline data expected H2 2026.
Verification
Confirm timing and program details against the company announcement or filing.